1. Home
  2. CRSP vs ALGM Comparison

CRSP vs ALGM Comparison

Compare CRSP & ALGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRSP
  • ALGM
  • Stock Information
  • Founded
  • CRSP 2013
  • ALGM 1990
  • Country
  • CRSP Switzerland
  • ALGM United States
  • Employees
  • CRSP N/A
  • ALGM N/A
  • Industry
  • CRSP Biotechnology: Biological Products (No Diagnostic Substances)
  • ALGM Semiconductors
  • Sector
  • CRSP Health Care
  • ALGM Technology
  • Exchange
  • CRSP Nasdaq
  • ALGM Nasdaq
  • Market Cap
  • CRSP 3.3B
  • ALGM 3.5B
  • IPO Year
  • CRSP 2016
  • ALGM 2020
  • Fundamental
  • Price
  • CRSP $44.25
  • ALGM $30.96
  • Analyst Decision
  • CRSP Buy
  • ALGM Strong Buy
  • Analyst Count
  • CRSP 15
  • ALGM 8
  • Target Price
  • CRSP $70.62
  • ALGM $29.13
  • AVG Volume (30 Days)
  • CRSP 2.5M
  • ALGM 1.7M
  • Earning Date
  • CRSP 08-04-2025
  • ALGM 07-31-2025
  • Dividend Yield
  • CRSP N/A
  • ALGM N/A
  • EPS Growth
  • CRSP N/A
  • ALGM N/A
  • EPS
  • CRSP N/A
  • ALGM N/A
  • Revenue
  • CRSP $37,675,000.00
  • ALGM $725,006,000.00
  • Revenue This Year
  • CRSP $30.25
  • ALGM $18.36
  • Revenue Next Year
  • CRSP $268.62
  • ALGM $18.98
  • P/E Ratio
  • CRSP N/A
  • ALGM N/A
  • Revenue Growth
  • CRSP N/A
  • ALGM N/A
  • 52 Week Low
  • CRSP $30.04
  • ALGM $16.38
  • 52 Week High
  • CRSP $63.68
  • ALGM $33.26
  • Technical
  • Relative Strength Index (RSI)
  • CRSP 68.22
  • ALGM 67.27
  • Support Level
  • CRSP $42.17
  • ALGM $28.48
  • Resistance Level
  • CRSP $47.04
  • ALGM $31.66
  • Average True Range (ATR)
  • CRSP 2.30
  • ALGM 1.05
  • MACD
  • CRSP 0.47
  • ALGM 0.10
  • Stochastic Oscillator
  • CRSP 74.56
  • ALGM 89.18

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

About ALGM Allegro MicroSystems Inc.

Allegro Microsystems Inc is a designer, developer, fabless manufacturer, and marketer of sensor ICs and application-specific analog power ICs for automotive and industrial markets. Its Sensor IC allows customers to precisely measure motion, speed, position, and current, and Power ICs include high-temperature and high-voltage capable motor drivers, power management, and LED driver ICs. Its products are divided into three categories such as SENSE which includes Current Sensors, Switches and Latches, and Interface ICs among others; REGULATE which includes Regulators, ClearPower Modules, and LED Drivers; and DRIVE which includes BLDC Drivers, Brush DC, and others. Key revenue for the company is generated from Greater China and the rest from the United States, Japan, Europe, and other regions.

Share on Social Networks: